# Motor segmentation: a key neuromuscular impairment in people with parkinson’s disease

**Authors:** Rebecca J. Daniels, Christopher A. Knight

PMC · DOI: 10.1007/s00221-025-07189-3 · Experimental Brain Research · 2025-11-02

## TL;DR

This study shows that a neuromuscular issue called motor segmentation is common in Parkinson’s patients and worsens their ability to produce rapid force.

## Contribution

The study identifies motor segmentation as a key impairment in Parkinson’s disease affecting force production.

## Key findings

- 68% of Parkinson’s patients showed motor segmentation, leading to slower force production.
- Segmentation was linked to consistent and shorter initial force segments in Parkinson’s patients.
- Patients without segmentation performed similarly to healthy adults in force metrics.

## Abstract

Healthy adults (OA) achieve rapid isometric force production with a brief, high amplitude burst of neural excitation. In some people with Parkinson’s disease (PwPD), transient reductions in neural excitation (motor segmentation) reduce rates of force development (RFD) and prolong contractions. Segmentation has strong relationships with time and rate-based measures of slowing in rapid contractions and is reliably measured from the second derivative of force (F”(t)). We sought more information about how segmentation affects neuromuscular control in PwPD. Aim 1 was to determine the prevalence of PwPD with segmentation (PDSeg). Aim 2 was to determine how force performance differs in PDSeg, PwPD without segmentation (PDNoSeg), and OA. Aim 3 was to quantify force segment durations. Fifty-seven PwPD ON medication and 22 OA performed rapid isometric finger abduction contractions to 20–60% of maximal voluntary contraction force. The median number of force segments to 90% of peak force were measured from F”(t) zero crossings. Additional outcomes included median times to peak force (tPF) and peak RFD (tRFD), and peak RFD (RFDpk). 68% of PwPD had segmentation (median segments ≥ 2, 95% CI [0.55 0.80]). PDSeg had slower tPF, tRFD and RFDpk than PDNoSeg and OA (all p ≤ 0.012, 0.38 ≤ r ≤ 0.85). PDNoSeg and OA did not have statistically different tPF, tRFD, or RFDpk (p > 0.05). PDSeg had consistent segment durations (coefficient of variation ≤ 25.5%) and shorter first segment durations compared to PDNoSeg and OA (p < 0.001, r ≥ 0.68), indicating PDSeg had reduced neuromuscular excitation prior to peak force. Segmentation identifies specific pathophysiology in neuromuscular control that exacerbates slowing in isometric force production.

## Linked entities

- **Diseases:** Parkinson’s disease (MONDO:0005180)

## Full-text entities

- **Diseases:** Parkinson's disease (MESH:D010300), neuromuscular impairment (MESH:D009468), OA (MESH:D010003)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12580443/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12580443/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12580443/full.md

---
Source: https://tomesphere.com/paper/PMC12580443